Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurological disorders
Biotech
Neuro biotech Nido closes after 5 years
Founded by 5AM Ventures’ 4:59 Initiative, Nido Biosciences publicly emerged in 2023 with $109 million and support from Big Pharma Eli Lilly.
Gabrielle Masson
Jan 2, 2026 10:24am
Voyager jettisons staff, Novartis hands back 2 programs
Dec 17, 2025 4:50pm
Merck KGaA becomes latest partner for Flagship’s Valo Health
Nov 20, 2025 6:30am
Big Pharma-backed MapLight plots IPO
Sep 22, 2025 1:57pm
Ionis rare disease candidate ekes out phase 3 win
Sep 22, 2025 10:46am
Servier supercharges neuro pipeline with $450M deal
Sep 8, 2025 2:30am
